120 related articles for article (PubMed ID: 37866309)
1. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma.
Sun G; Chen H; Xia J; Li T; Ye H; Li J; Zhang X; Cheng Y; Wang K; Shi J; Wang P
Int Immunopharmacol; 2023 Dec; 125(Pt A):111041. PubMed ID: 37866309
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Cheng L; Ren P; Shi J; Dai L; Wang P; Zhang J
Oncoimmunology; 2020 Sep; 9(1):1814515. PubMed ID: 33457096
[TBL] [Abstract][Full Text] [Related]
6. Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.
Sun G; Ye H; Yang Q; Zhu J; Qiu C; Shi J; Dai L; Wang K; Zhang J; Wang P
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e582-e592. PubMed ID: 37433700
[TBL] [Abstract][Full Text] [Related]
7. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
Wang C; Sun G; Wang H; Dai L; Zhang J; Du R
BMC Cancer; 2022 Aug; 22(1):932. PubMed ID: 36038839
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Zhou JH; Zhang B; Kernstine KH; Zhong L
World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
[TBL] [Abstract][Full Text] [Related]
10. Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
Chen H; Sun G; Han Z; Wang H; Li J; Ye H; Song C; Zhang J; Wang P
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295640
[No Abstract] [Full Text] [Related]
11. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
13. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer.
Zhang HF; Qin JJ; Ren PF; Shi JX; Xia JF; Ye H; Wang P; Song CH; Wang KJ; Zhang JY
Cancer Immunol Immunother; 2016 Oct; 65(10):1233-42. PubMed ID: 27553002
[TBL] [Abstract][Full Text] [Related]
14. Investigation of melanoma-associated antigen A4 cancer/testis antigen clinical relevance in esophageal squamous cell carcinoma.
Sani SA; Forghanifard MM; Sharifi N; Bidokhti MH; Bagherpoor AJ; Abbaszadegan MR
J Cancer Res Ther; 2018; 14(5):1059-1064. PubMed ID: 30197348
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
16. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
[TBL] [Abstract][Full Text] [Related]
18. Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma.
Zheng Q; Zhang L; Tu M; Yin X; Cai L; Zhang S; Yu L; Pan X; Huang Y
Clin Chim Acta; 2021 Sep; 520():126-132. PubMed ID: 34119530
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma.
Tang WW; Liu ZH; Yang TX; Wang HJ; Cao XF
Onco Targets Ther; 2016; 9():4289-93. PubMed ID: 27478386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
